Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLife Settlemen Regulatory News (LSAA)

Share Price Information for Life Settlemen (LSAA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.70
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.20 (12.50%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1.70
LSAA Live PriceLast checked at -
Life Settlement Assets A is an Investment Trust

To generate long-term returns for investors by investing in the life settlement market.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Share Buyback Programme

6 Aug 2019 07:00

RNS Number : 9710H
Life Settlement Assets PLC
06 August 2019
 

6 August 2019

Life Settlement Assets PLC (the "Company" or "LSA")

LEI: 2138003OL2VBXWG1BZ27

Share Buyback Programme

Further to the Company's announcements of 14 May 2019 and 13 June 2019, the Company announces the launch of a buyback programme in respect of up to a maximum of US$0.5 million for D Ordinary Shares and up to a maximum of US$0.5 million for E Ordinary Shares ("Buyback Programme").

The Buyback Programme will commence with effect from 12 August 2019 and shall continue until the earlier of the maximum amounts being repurchased and 24 September 2019. The maximum amount of money allocated for the Buyback Programme is US$0.5 million for D Ordinary Shares and US$0.5 million for E Ordinary Shares.

The Company has engaged Shore Capital Stockbrokers ("Shore"), the Company's broker, to conduct the Buyback Programme, which will be independently managed by Shore, the Company's broker, which will make trading decisions independently and without the influence of the Company.

Pursuant to, and during the term of, the Buyback Programme, the Company may purchase D Ordinary Shares and E Ordinary Shares provided that:

1) the maximum price which may be paid for D Ordinary Shares or E Ordinary Shares on the Exchange is the higher of:

a. an amount equal to 5% above the average of the middle market quotations for an Ordinary Share of the relevant class as derived from the Daily Official List of the London Stock Exchange plc for the five business days immediately preceding the day on which that Ordinary Share is contracted to be purchased; and

b. an amount equal to the higher of the price of the last independent trade and the highest current independent bid on the trading venues where the purchase is carried out at the relevant time.

2) any purchase of Ordinary Shares will be made in the market for cash at prices below the latest estimated monthly net asset value per share of the relevant class (as determined by the Directors).

D Ordinary Shares and E Ordinary Shares purchased under the Buyback Programme will be cancelled and consequently will reduce the number of Ordinary Shares of that class. As Ordinary Shares will not be acquired above the prevailing net asset value per share, the Buyback Programme is expected to enhance net asset value per D Ordinary Share and E Ordinary Share.

Due to the limited liquidity in trading of the Company's D Ordinary Shares and E Ordinary Shares, purchases under the Buyback Programme on any trading day are likely to represent a significant proportion of the daily trading volume in the shares of that class (and are likely to exceed the 25% threshold of the average daily trading volume in both the month preceding this announcement and the 20 trading days preceding the date of the purchase as is set out in the Commission Delegated Regulation (EU) 2016/1052) and, as such, the Company would be deviating from the safe harbour set out in Article 5(1) of the Market Abuse Regulation (Regulation 596/2014).

The Company will announce any market repurchase no later than 7.30am on the business day following the calendar on which the repurchase occurred.

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.The Company confirms that it currently has no other unpublished price sensitive information other than what has been disclosed above.

Enquiries:

Acheron Capital Limited (Investment Manager) 

Jean-Michel Paul 

020 7258 5990 

 

Shore Capital (Financial Adviser and Broker) 

Robert Finlay

020 7408 4080

 

George Bayer / Kerry Higgins 

Maitland Administration Services Limited 

Company Secretary  

Tel: 01245 209780 

 

TB Cardew (Financial PR) 

Shan Shan Willenbrock 

020 7930 0777 

 

Notes to Editors

LSA is a closed-ended investment company which manages portfolios of whole and fractional interests in life settlement policies issued by life insurance companies operating predominantly in the United States. The life settlement market enables individuals to sell their life insurance policies to investors at a higher cash value than they would otherwise receive from insurance companies (if they were cancelled or surrendered at the date of sale). The Company aims to manage portfolios of life settlement products so that the realised value of the policy maturities exceeds the aggregate cost of acquiring the policies, ongoing premiums, management fees and other operational costs. LSA is listed on the Specialist Fund Segment of the Main Market of the London Stock Exchange.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCUGUQURUPBGMA
Date   Source Headline
1st Mar 20244:13 pmRNSPolicy Maturities
1st Mar 20243:40 pmRNSNet Asset Value(s)
15th Feb 20243:00 pmRNSDividend Declaration
2nd Feb 20244:15 pmRNSNet Asset Value(s)
24th Jan 20249:54 amRNSNet Asset Value(s)
20th Dec 20237:00 amRNSPolicy Maturities and update on MBC settlement
13th Dec 202310:35 amRNSHolding(s) in Company
13th Nov 20239:34 amRNSNet Asset Value(s)
17th Oct 20235:14 pmRNSNet Asset Value(s)
27th Sep 20237:00 amRNSHalf-year Report
20th Sep 202311:53 amRNSNet Asset Value(s)
18th Aug 20239:52 amRNSNet Asset Value(s)
17th Jul 20231:06 pmRNSNet Asset Value(s)
14th Jun 20234:14 pmRNSAGM Statement
2nd Jun 202310:17 amRNSNet Asset Value(s)
30th May 202312:33 pmRNSNet Asset Value(s)
16th May 202312:26 pmRNSNet Asset Value(s)
28th Apr 20237:00 amRNSFinal Results
5th Apr 20239:33 amRNSNet Asset Value(s)
5th Apr 20237:00 amRNSUpdate on MBC Auction
6th Mar 20233:22 pmRNSHolding(s) in Company
6th Mar 20237:00 amRNSUpdate on MBC Auction
23rd Feb 20233:25 pmRNSNet Asset Value(s)
23rd Feb 20231:56 pmRNSHolding(s) in Company
2nd Feb 20237:00 amRNSDividend Declaration
27th Jan 20234:44 pmRNSUpdate on MBC Auction
16th Jan 202311:40 amRNSNet Asset Value(s)
30th Dec 20227:00 amRNSUpdate on MBC Auction
12th Dec 20227:00 amRNSUpdate on MBC Auction
5th Dec 20222:40 pmRNSStatement re MBC Auction
2nd Dec 20226:21 pmRNSNet Asset Value(s)
14th Nov 202211:24 amRNSNet Asset Value(s)
29th Sep 20223:42 pmRNSNet Asset Value(s)
28th Sep 20227:00 amRNSHalf-year Report
8th Sep 20221:32 pmRNSNet Asset Value(s)
10th Aug 202210:09 amRNSNet Asset Value(s)
12th Jul 20225:35 pmRNSHolding(s) in Company
7th Jul 202212:07 pmRNSNet Asset Value(s)
30th Jun 20227:00 amRNSStatement re agreement to reduce performance fee
23rd Jun 20224:22 pmRNSResult of Annual General Meeting
22nd Jun 20224:56 pmRNSNet Asset Value(s)
26th May 202210:56 amRNSNet Asset Value(s)
23rd May 20222:16 pmRNSNet Asset Value(s)
22nd Apr 20227:00 amRNSFinal Results
30th Mar 202210:03 amRNSNet Asset Value(s)
2nd Mar 202211:22 amRNSNet Asset Value(s)
16th Feb 20224:41 pmRNSHolding(s) in Company
19th Jan 20221:05 pmRNSNet Asset Value(s)
21st Dec 202112:08 pmRNSHolding(s) in Company
15th Dec 202110:07 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.